Healthcare & Life Sciences
Slatebio
United Statesslatebio.com
Slatebio is a startup based in the United States, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About Slatebio
Slatebio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Slatebio develops advanced regulatory T cell (T reg) therapies to treat autoimmune diseases.
Explore Slatebio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.